119-1631

A bill to require the Secretary of Health and Human Services to approve a risk evaluation and mitigation strategy for mifepristone that is identical to the strategy previously approved, and for other purposes.

Last action was on 2-26-2025

Bill is currently in: House
Path to Law
House Senate President

Current status is Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

View Official Bill Information at congress.gov

No users have voted for/against support on this bill yet. Be the first!